A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

A study found that some long COVID patients who took Paxlovid saw improvement. But experts said the research isn't enough to ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache, nausea ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

State surveyors struggled to get Minnesotans to talk about their post-COVID health, but found a high rate of symptoms such as ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

There's no medication for norovirus. Instead, you'll need to rehydrate as much as possible with water and other liquids. Seek ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...